World Health Organization Issues Warning Over Acute Lack of Obesity Injections

Fewer than a tenth of individuals who could benefit from GLP-1 drugs including Wegovy can access them, states the global health agency as it issues its first recommendations on the medications.

With in excess of 1,000,000,000 people worldwide now living with obesity, it is advocating for broader and more equitable access to these injectable treatments.

Per estimates, more than two billion are projected to be obese by 2030 if no action is taken.

"The latest guidelines acknowledges that obesity is a lifelong illness that can be addressed with thorough and ongoing care," said WHO director-general Tedros Adhanom Ghebreyesus.

High costs, constrained manufacturing, and supply-chain constraints are significant obstacles to widespread access to the injections that can aid individuals in losing substantial weight, notes the organization.

Weight-Loss Drug Scarcity

Even in the current most favorable scenario, the supply of GLP-1 therapies might only reach around 100 million people – less than 10% of eligible patients, per the health organization.

The guideline encourages governments and firms to widen availability, through strategies like voluntary licensing.

The intellectual property rights on a key compound – the primary ingredient of a leading brand – is set to lapse in multiple nations in 2026.

The Way Obesity Jabs Work

These medications mimick a biological compound to reduce digestion speed, curb appetite and boost the sense of being full so individuals consume fewer calories.

Patients usually start to lose weight within a few weeks of starting on the once-weekly jabs.

Evidence points to people may see weight return within a year of discontinuing the treatment, as their typical appetite come back.

To be carrying excess weight elevates your likelihood for developing health problems, like type 2 diabetes, cardiovascular issues, stroke, and certain malignancies.

Excess weight affects people in every country and was responsible for millions of deaths worldwide in 2024, per the WHO.

Christopher White
Christopher White

Elara Vance is a film critic and entertainment journalist with over a decade of experience covering Hollywood and indie cinema.